Save your place

Sign in to WhoBought

Please try again later.

Journey Medical Corporation (DERM) institutional ownership

Latest close $7.09 Jul 20, 2026
Market cap$179M 52-week range SectorHealthcare
Funds holding · Q1 2026
74
reported DERM position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
40 buyers · 34 sellers

Journey Medical Corporation (DERM) price and institutional activity

Dates

Q1 2026

$0 bought by 40 investors
Wasatch Advisors LPVanguard +38 more
$0 sold by 34 investors
Essex Investment Management Co LLCJ. Goldman & Co LP +32 more
Sign in to see who bought
Bought Sold Totals per quarter; hover a bar for the names.

Journey Medical Corporation (DERM) institutional activity · 74

Investor Type Est. change Change Δ Own Date
Wasatch Advisors LP · Added
Change +817K Date Q1 2026
Wasatch Advisors LP Added· Q1 2026 +817K Q1 2026
Vanguard · Added
Change +583K Date Q1 2026
Vanguard Added· Q1 2026 +583K Q1 2026
Essex Investment Management Co LLC · Exited
Change −346K Δ Own −100.0% Date Q1 2026
Essex Investment Management Co LLC Exited· Q1 2026 −346K −100.0% Q1 2026
J. Goldman & Co LP · Reduced
Change −298K Date Q1 2026
J. Goldman & Co LP Reduced· Q1 2026 −298K Q1 2026
BlackRock · Added
Change +253K Date Q1 2026
BlackRock Added· Q1 2026 +253K Q1 2026
Tang Capital Management LLC · Reduced
Change −245K Date Q1 2026
Tang Capital Management LLC Reduced· Q1 2026 −245K Q1 2026
Geode · Added
Change +149K Date Q1 2026
Geode Added· Q1 2026 +149K Q1 2026
Diametric Capital, LP · Added
Change +145K Date Q1 2026
Diametric Capital, LP Added· Q1 2026 +145K Q1 2026
Legato Capital Management LLC · Exited
Change −112K Δ Own −100.0% Date Q1 2026
Legato Capital Management LLC Exited· Q1 2026 −112K −100.0% Q1 2026
UBS Group AG · Added
Change +100K Date Q1 2026
UBS Group AG Added· Q1 2026 +100K Q1 2026
Informed Momentum Co LLC · Exited
Change −89K Δ Own −100.0% Date Q1 2026
Informed Momentum Co LLC Exited· Q1 2026 −89K −100.0% Q1 2026
Millennium Management LLC · Reduced
Change −75K Date Q1 2026
Millennium Management LLC Reduced· Q1 2026 −75K Q1 2026
Citadel Advisors LLC Exited· Q1 2026 −69K −100.0% Q1 2026
State Street · Added
Change +64K Date Q1 2026
State Street Added· Q1 2026 +64K Q1 2026
Geneos Wealth Management Inc. · Exited
Change −63K Δ Own −100.0% Date Q1 2026
Geneos Wealth Management Inc. Exited· Q1 2026 −63K −100.0% Q1 2026
Data through Q1 2026 · filed May 15, 2026
15 of 74

Famous investor activity in Journey Medical Corporation (DERM)

Journey Medical Corporation (DERM) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Toledano Miranda Jayne · Director Grant (A) 50K
Owned 169K ΔOwn +42.2% Trade date Jul 1, 2026 Filed date Jul 2, 2026
Toledano Miranda Jayne Director Grant (A) 50K 169K +42.2% Jul 1, 2026 Jul 2, 2026
Smith Justin Adam · Director Grant (A) 50K
Owned 232K ΔOwn +27.5% Trade date Jul 1, 2026 Filed date Jul 2, 2026
Smith Justin Adam Director Grant (A) 50K 232K +27.5% Jul 1, 2026 Jul 2, 2026
Herskowitz Neil · Director Grant (A) 50K
Owned 169K ΔOwn +42.2% Trade date Jul 1, 2026 Filed date Jul 2, 2026
Herskowitz Neil Director Grant (A) 50K 169K +42.2% Jul 1, 2026 Jul 2, 2026
Toledano Miranda Jayne · Director Grant (A) 10K
Owned 119K ΔOwn +9.2% Trade date Jun 25, 2026 Filed date Jun 29, 2026
Toledano Miranda Jayne Director Grant (A) 10K 119K +9.2% Jun 25, 2026 Jun 29, 2026
Smith Justin Adam · Director Grant (A) 10K
Owned 182K ΔOwn +5.8% Trade date Jun 25, 2026 Filed date Jun 26, 2026
Smith Justin Adam Director Grant (A) 10K 182K +5.8% Jun 25, 2026 Jun 26, 2026
Herskowitz Neil · Director Grant (A) 10K
Owned 119K ΔOwn +9.2% Trade date Jun 25, 2026 Filed date Jun 26, 2026
Herskowitz Neil Director Grant (A) 10K 119K +9.2% Jun 25, 2026 Jun 26, 2026
Pearce Michael Cooper · Director Grant (A) 10K
Owned 67K ΔOwn +17.5% Trade date Jun 25, 2026 Filed date Jun 26, 2026
Pearce Michael Cooper Director Grant (A) 10K 67K +17.5% Jun 25, 2026 Jun 26, 2026
Rosenwald Lindsay A. Md · Director Grant (A) 10K
Owned 221K ΔOwn +4.7% Trade date Jun 25, 2026 Filed date Jun 26, 2026
Rosenwald Lindsay A. Md Director Grant (A) 10K 221K +4.7% Jun 25, 2026 Jun 26, 2026
Alloush Ramsey · Officer 2 operations 110K
Owned 63K Trade date Apr 22, 2026 Filed date Apr 24, 2026
Alloush Ramsey Officer 2 operations 110K 63K Apr 22, 2026 Apr 24, 2026
Benesch Joseph · CFO 2 operations 71K
Owned 42K Trade date Apr 22, 2026 Filed date Apr 24, 2026
Benesch Joseph CFO 2 operations 71K 42K Apr 22, 2026 Apr 24, 2026
Maraoui Claude · Director 2 operations 132K
Owned 83K Trade date Apr 22, 2026 Filed date Apr 24, 2026
Maraoui Claude Director 2 operations 132K 83K Apr 22, 2026 Apr 24, 2026
Maraoui Claude · Director, Officer 2 operations 0
Price $0.07 Owned 0 Trade date Aug 25, 2025 Filed date Aug 26, 2025
Maraoui Claude Director, Officer 2 operations $0.07 0 0 Aug 25, 2025 Aug 26, 2025
Maraoui Claude · Director, Officer Tax withholding or exercise payment (F) -$81K
Price $7.47 Qty -11K Owned 2.4M Trade date Aug 25, 2025 Filed date Aug 26, 2025
Maraoui Claude Director, Officer Tax withholding or exercise payment (F) $7.47 -11K -$81K 2.4M Aug 25, 2025 Aug 26, 2025
Rosenwald Lindsay A. Md · Director Grant (A) 50K
Owned 211K Trade date Aug 5, 2025 Filed date Aug 7, 2025
Rosenwald Lindsay A. Md Director Grant (A) 50K 211K Aug 5, 2025 Aug 7, 2025
Smith Justin Adam · Director Grant (A) 20K
Owned 172K Trade date Aug 5, 2025 Filed date Aug 7, 2025
Smith Justin Adam Director Grant (A) 20K 172K Aug 5, 2025 Aug 7, 2025
15 of 18
15 of 18 Sign in to continue to older insider transactions.

Journey Medical Corporation (DERM) activist and large shareholders

What are Schedules 13D and 13G?

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Fortress Biotech, Inc. 10.0M
% of shares outstanding 56.9% Filing date Aug 17, 2022
Fortress Biotech, Inc. 10.0M 56.9% Aug 17, 2022
Wasatch Advisors LP 2.9M
% of shares outstanding 13.3% Filing date Jul 15, 2026
Wasatch Advisors LP 2.9M 13.3% Jul 15, 2026
Tang Capital Management LLC 1.9M
% of shares outstanding 8.0% Filing date May 15, 2025
Tang Capital Management LLC 1.9M 8.0% May 15, 2025
Vanguard Capital Management LLC 1.2M
% of shares outstanding 5.7% Filing date Apr 30, 2026
Vanguard Capital Management LLC 1.2M 5.7% Apr 30, 2026
Wasatch Advisors LP 931K
% of shares outstanding 5.4% Filing date May 13, 2025
Wasatch Advisors LP 931K 5.4% May 13, 2025
B. Riley Financial, Inc. 865K
% of shares outstanding 4.9% Filing date Dec 29, 2022
B. Riley Financial, Inc. 865K 4.9% Dec 29, 2022
6 of 6

Journey Medical Corporation (DERM) ownership FAQ

Who owns DERM?

74 reporting institutions disclosed DERM position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.